Dimethoxytrityl‐Protected Oligonucleotide Purification With On‐Column Detritylation in Hydrophobic Interaction Chromatography
Journal of Separation Science · 2026-11 · 49 (11)
DOI: 10.1002/jssc.70583 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Separation Science, online erschienen am 13.11.2026. Verfasst von William E Evans und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tosoh Bioscience LLC, King of Prussia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Oligonucleotides. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tosoh Bioscience LLC.
Abstract (Originalsprache)
State‐of‐the‐art techniques using synthetic antisense oligonucleotides and other nucleotide‐based therapeutics have transformed treatment for a wide range of diseases, including neurological, metabolic, cardiovascular, and muscular disorders, many of which were previously incurable. As the biopharmaceutical industry expands into this new therapeutic field, there is increasing demand for robust purification and analytical techniques. Therapeutic oligonucleotides are most often purified by ion pair‐reversed phase (IP‐RP) and anion‐exchange (AEX) chromatography techniques. Here, we present a single‐step chromatography approach utilizing hydrophobic interaction chromatography (HIC) for a 5′‐dimethoxytrityl (5′‐DMT)‐protected 20‐mer single‐stranded DNA oligonucleotide. The HIC process incorporates an optimized on‐column detritylation step at pH 4.0, enabling removal of the 5′‐DMT protective cap from the purified oligonucleotide. This method also effectively eliminated the majority of < 20‐mer oligonucleotide impurities, which were present as deprotected oligonucleotides in the crude starting material. Analytical RP and AEX chromatography methods confirmed nearly complete (99.6%) 5′‐DMT removal and an oligonucleotide recovery rate of 96.9% for the final product. Moreover, an RP chromatographic depurination assay demonstrated that the acidic detritylation procedure did not result in detrimental adenine or guanine purine base loss. The all‐aqueous HIC process is environmentally friendly and avoids the flammability risks associated with RP technique.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tosoh Bioscience LLC, King of Prussia, Pennsylvania, USA.
- Tosoh Corporation, Bioscience Division, Shunan, Yamaguchi, Japan.
- Tosoh Bioscience GmbH, Griesheim, Germany.
Förderung
- Tosoh Bioscience LLC
Zitieren
APA
Evans, W. E., Bonakdar, L., Duong, P., Kobayashi, H., Wege, J., Endres, P., Müller, E., Dabre, R., & Kervinen, J. (2026). Dimethoxytrityl‐Protected Oligonucleotide Purification With On‐Column Detritylation in Hydrophobic Interaction Chromatography. Journal of Separation Science, 49(11). https://doi.org/10.1002/jssc.70583
Vancouver
Evans WE, Bonakdar L, Duong P, Kobayashi H, Wege J, Endres P, et al. Dimethoxytrityl‐Protected Oligonucleotide Purification With On‐Column Detritylation in Hydrophobic Interaction Chromatography. Journal of Separation Science. 2026;49(11). doi:10.1002/jssc.70583
BibTeX
@article{Evans2026,
author = {Evans, William E and Bonakdar, Leila and Duong, Phu and Kobayashi, Hidetaka and Wege, Jonas and Endres, Patrick and Müller, Egbert and Dabre, Romain and Kervinen, Jukka},
title = {Dimethoxytrityl‐Protected Oligonucleotide Purification With On‐Column Detritylation in Hydrophobic Interaction Chromatography},
journal = {Journal of Separation Science},
year = {2026},
volume = {49},
number = {11},
doi = {10.1002/jssc.70583}
}
EUVIMED